Yanyan Zhang, Zhaohui Pei, Beijian Chen, Yanling Qu, Xiaolin Dong, Binge Yu, . . . Yong Huo. (2024). Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab. Elsevier.
Chicago Style (17th ed.) CitationYanyan Zhang, et al. Ebronucimab in Chinese Patients with Hypercholesterolemia---A Randomized Double-blind Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Ebronucimab. Elsevier, 2024.
MLA (9th ed.) CitationYanyan Zhang, et al. Ebronucimab in Chinese Patients with Hypercholesterolemia---A Randomized Double-blind Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Ebronucimab. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.